Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Other Non-Current Assets (2021 - 2025)

Prime Medicine's Other Non-Current Assets history spans 5 years, with the latest figure at $13.7 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets changed N/A year-over-year to $13.7 million; the TTM value through Dec 2025 reached $13.7 million, changed N/A, while the annual FY2025 figure was $13.7 million, N/A changed from the prior year.
  • Other Non-Current Assets reached $13.7 million in Q4 2025 per PRME's latest filing, roughly flat from $13.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $14.1 million in Q3 2024 to a low of $779000.0 in Q4 2023.
  • Average Other Non-Current Assets over 5 years is $12.0 million, with a median of $13.5 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: tumbled 87.46% in 2022, then increased 4.19% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $13.1 million in 2021, then crashed by 87.46% to $1.6 million in 2022, then plummeted by 52.67% to $779000.0 in 2023, then surged by 1705.13% to $14.1 million in 2024, then decreased by 2.64% to $13.7 million in 2025.
  • Per Business Quant, the three most recent readings for PRME's Other Non-Current Assets are $13.7 million (Q4 2025), $13.7 million (Q3 2025), and $13.7 million (Q2 2025).